References
1. P G, J V, L Z, C T, S A. Antigen presentation and T cell stimulation by dendritic cells. Annual review of immunology 2002; 20:621-67.
2. Hubo M, Trinschek B, Kryczanowsky F, Tuettenberg A, Steinbrink K, Jonuleit H. Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Front Immunol 2013; 4:82.
3. De Sousa C P, CM B, EP S, AM C, RA K. Murine mammary carcinoma cells and CD11c(+) dendritic cells elicit distinct responses to lipopolysaccharide and exhibit differential expression of genes required for TLR4 signaling. Cellular immunology 2010; 266:67-75.
4. M L, W D, X Z, H H, A N, JR G. Therapeutic induction of tolerance by IL-10-differentiated dendritic cells in a mouse model of house dust mite-asthma. Allergy 2011; 66:612-20.
5. F Z, B C, GX Z, A R. Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis. Clinical and experimental immunology 2014; 178:447-58.
6. F Z, GX Z, A R. LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4 regulatory T cell subpopulations mediated by 3G11 and CD127. Immunologic research 2017; 65:630-8.
7. de Aragao-Franca LS, Aragao-Franca LS, Rocha V, Rocha V, Cronemberger-Andrade A, Da CF, et al. Tolerogenic Dendritic Cells Reduce Airway Inflammation in a Model of Dust Mite Triggered Allergic Inflammation. Allergy Asthma Immunol Res 2018; 10:406-19.
8. U S, P R. Tolerogenic dendritic cells: molecular and cellular mechanisms in transplantation. Journal of leukocyte biology 2014; 95:53-69.
9. Bol KF, Schreibelt G, Gerritsen WR, de Vries IJ, Figdor CG. Dendritic Cell-Based Immunotherapy: State of the Art and Beyond. Clin Cancer Res 2016; 22:1897-906.
10. Yoo S, Ha SJ. Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications. Immune Netw 2016; 16:52-60.
11. MA B, JR K, MS H, JJ Z, van Ham SM, A TB. IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction–a comparative study of human clinical-applicable DC. Clinical immunology (Orlando, Fla.) 2012; 142:332-42.
12. M L, W D, X Z, H H, A N, JR G. Therapeutic induction of tolerance by IL-10-differentiated dendritic cells in a mouse model of house dust mite-asthma. Allergy 2011; 66:612-20.
13. Huang H, Dawicki W, Lu M, Nayyar A, Zhang X, Gordon JR. Regulatory dendritic cell expression of MHCII and IL-10 are jointly requisite for induction of tolerance in a murine model of OVA-asthma. Allergy 2013; 68:1126-35.
14. T K, H M, K T, S M, N M, A B, et al. IL-10-treated dendritic cells decrease airway hyperresponsiveness and airway inflammation in mice. The Journal of allergy and clinical immunology 2007; 119:1241-50.
15. De Smedt T, Van Mechelen M, De Becker G, J U, O L, M M. Effect of interleukin-10 on dendritic cell maturation and function. European journal of immunology 1997; 27:1229-35.
16. S F, N Y, Y I, Y S, K S, K E, et al. Regulatory dendritic cells protect against allergic airway inflammation in a murine asthmatic model. The Journal of allergy and clinical immunology 2008; 121:95-104.
17. R K, J W, JR O, G J, J Z, KA S, et al. Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg. European journal of immunology 2010; 40:1022-35.
18. YG K, CH S, HK Y, PH H, JS K, KS L, et al. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. The Journal of clinical investigation 2003; 111:1083-92.
19. F F, D F, A S, S R, L R, A M, et al. Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor. Journal of immunology (Baltimore, Md. : 1950) 1998; 161:342-6.
20. J B, RM S. Dendritic cells and the control of immunity. Nature 1998; 392:245-52.
21. AS A, RR H, F A, KA A. Changing survival, memory cell compartment, and T-helper balance of lymphocytes between severe and mild asthma. BMC immunology 2008; 9:73.
22. M P, MK J. Origins of CD4(+) effector and central memory T cells. Nature immunology 2011; 12:467-71.
23. F S, J G, A L. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annual review of immunology 2004; 22:745-63.
24. H H, W D, X Z, J T, JR G. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells. Journal of immunology (Baltimore, Md. : 1950) 2010; 185:5003-10.
25. SS A. Targeting cell signaling in allergic asthma. Signal transduction and targeted therapy 2019; 4:45.
26. Chen Z, Wang S, Erekosima N, Li Y, Hong J, Qi X, et al. IL-4 confers resistance to IL-27-mediated suppression on CD4+ T cells by impairing signal transducer and activator of transcription 1 signaling. J Allergy Clin Immunol 2013; 132:912-21.
27. K S, M W, H J, J K, AH E. Pillars Article: Induction of Tolerance by IL-10-Treated Dendritic Cells. J. Immunol. 1997. 159: 4772-4780. Journal of immunology (Baltimore, Md. : 1950) 2016; 197:1547-55.
28. KK E, S T, F N, KG W, VW Y, QJ P, et al. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. Journal of immunology (Baltimore, Md. : 1950) 2009; 183:298-309.
29. Nayyar A, Dawicki W, Huang H, Lu M, Zhang X, Gordon JR. Induction of prolonged asthma tolerance by IL-10-differentiated dendritic cells: differential impact on airway hyperresponsiveness and the Th2 immunoinflammatory response. J Immunol 2012; 189:72-9.
30. D Z, Q C, VW L, Y W, G Z, Y W, et al. Lipopolysaccharide-pretreated plasmacytoid dendritic cells ameliorate experimental chronic kidney disease. Kidney international 2012; 81:892-902.
31. B A, T F, RD R, AM D, D Q, A H, et al. Lipopolysaccharide stimulation of dendritic cells induces interleukin-10 producing allergen-specific T cells in vitro but fails to prevent allergic airway disease. Experimental lung research 2009; 35:307-23.
32. I B, S S, B K, AB R, J K, J S. Interleukin-10-treated dendritic cells do not inhibit Th2 immune responses in ovalbumin/alum-sensitized mice. International archives of allergy and immunology 2006; 141:61-9.
33. X L, A Y, H H, X Z, J T, B D, et al. Induction of type 2 T helper cell allergen tolerance by IL-10-differentiated regulatory dendritic cells. American journal of respiratory cell and molecular biology 2010; 42:190-9.
34. AE A, DJ S, BL S, RA H, AM P, von Delwig A, et al. LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. Journal of leukocyte biology 2009; 85:243-50.
35. SJ B, WJ M, CA W, MI G. A role for Th2 T-memory cells in early airway obstruction. Cellular immunology 1996; 170:185-94.
36. JR L, DL F. Generation, persistence and plasticity of CD4 T-cell memories. Immunology 2010; 130:463-70.
37. M L, W D, X Z, H H, A N, JR G. Therapeutic induction of tolerance by IL-10-differentiated dendritic cells in a mouse model of house dust mite-asthma. Allergy 2011; 66:612-20.
38. S M, T M, T K, Y N, K K, K T, et al. STAT6 deficiency in a mouse model of allergen-induced airways inflammation abolishes eosinophilia but induces infiltration of CD8+ T cells. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1999; 29:114-23.
39. DH S, PA S, GR Z, LS S, JA T, DJ T, et al. Reversal of airway hyperresponsiveness by induction of airway mucosal CD4+CD25+ regulatory T cells. The Journal of experimental medicine 2006; 203:2649-60.
40. BD M, E S, S H, SY T, BP S, JS D, et al. CD11b+ myeloid cells are the key mediators of Th2 cell homing into the airway in allergic inflammation. Journal of immunology (Baltimore, Md. : 1950) 2009; 182:623-35.